Ready to build your own Founder-Led Growth engine? Book a Strategy Call
Frontlines.io | Where B2B Founders Talk GTM.
Strategic Communications Advisory For Visionary Founders
Actionable
Takeaways
Time product-market readiness against defensible data moats, not funding cycles:
Colin invested 8-9 years collecting a billion hours of sleep data and publishing 100+ studies before scaling commercialization. This created inbound demand from companies with unsolved problems and established technical credibility that competitors can't replicate quickly. For deep-tech B2B founders, premature go-to-market before achieving technical differentiation means competing on sales execution rather than product superiority. The German reimbursement approval—a multi-year regulatory process requiring robust clinical evidence—exemplifies outcomes only accessible with patience.
Collapse the technical-commercial divide by embedding experts in revenue processes:
Sleep AI's scientists participate in sales conversations from initial discovery through close. This isn't consultation—it's full integration. The cultural frame Colin established: "innovation and scientific breakthroughs are great if they have an impact, but if they stay in a box...they have no impact." For technical founders, this means your PhD-level team must own customer outcomes, not just product capabilities. If your best technical minds aren't in customer conversations, you're leaving competitive advantage on the table.
Position as infrastructure when solving complex, multi-intervention problems:
Colin recognized no single company can solve sleep comprehensively—it requires medical diagnosis, environmental optimization, behavioral coaching, and product interventions. Rather than attempting vertical integration, Sleep AI built horizontal infrastructure (SDK/API) that makes other health companies better. The insight: "We want to reach a billion people through the companies that they already trust by being their trusted sleep partner." Infrastructure plays generate winner-take-most outcomes in fragmented markets where solution complexity exceeds any single vendor's scope.
Design outcome-based positioning that transcends feature wars:
Sleep AI doesn't compete on measurement accuracy—they're "agnostic as to whether you want to wear a whoop or a ring or nothing at all." The value proposition centers on turning abundant data into intelligence that drives health outcomes. This positioning works because measurement is commoditizing while interpretation and intervention guidance remain hard problems. B2B founders should ask: are we selling the commodity layer (features) or the intelligence layer (outcomes)?
Leverage existing customer relationships as systematic distribution channels:
Sleep AI built structured referral programs between customers to accelerate pipeline generation. In B2B infrastructure plays, your customers' distribution becomes your distribution—but only if you architect formal programs rather than hoping for organic word-of-mouth. The compounding effect: each new customer adds partnership opportunities, vendor validation, and integration references that accelerate subsequent deals.
Use regulatory wins as category-defining moats:
The German reimbursement achievement—making Sleep AI's app available to 74 million people with mandated insurer payment and no prescription requirement—establishes precedent that competitors must now match. Colin positions this as validation that "the German government gets it" on preventative healthcare economics. Regulatory approvals in healthcare, fintech, and other governed markets create multi-year competitive separation while signaling product rigor to other buyers.
Conversation
Highlights
How Sleep AI Spent 8 Years Building a Billion-Hour Data Moat Before Hiring Their First Salesperson
Most B2B founders face pressure to prove commercial traction within 18 months of launching. Colin Lawlor ignored that pressure entirely.
The Sleep AI founder spent eight years in deep R&D mode—collecting a billion hours of sleep data from over a million users and publishing 100+ peer-reviewed studies—before hiring his first sales or marketing employee. No outbound motion. No paid acquisition. Just building until the technical credibility became undeniable.
“In Ireland, you kind of culturally, you don’t start to brag about something until you have it,” Colin explains in a recent episode of BUILDERS. “But I do know that there’s also fake it till you make it. It’s a valid strategy. But we just couldn’t do that.”
The result: companies with real sleep validation problems found Sleep AI organically during those eight years, creating initial revenue without any commercial infrastructure.
The $100 Billion Validation Gap
Colin’s path into sleep technology started with a mentor’s question decades earlier about extracting productivity from sleep hours. But building a company required identifying a specific market failure.
He found it: “There’s a $100 billion sleep market out there. There are somewhere in the region of 10,000 separate SKUs and products, and so far, probably no more than 300 of them have ever been measured scientifically in terms of the effect they have on people’s sleep.”
The opportunity wasn’t another consumer sleep product. It was building the measurement and validation infrastructure the entire industry lacked. Sleep AI’s first business line emerged directly from this gap: providing data services to companies developing sleep products who needed to prove their solutions actually worked.
Solving the Data-to-Intelligence Problem
Modern sleep tracking creates a new problem: too much data with insufficient interpretation. Colin quantifies this with his personal example: “I collect for me half a million data points a year, right? Just for me. So you can imagine walking into your doctor and saying, hey, look, here’s my phone, here’s half a million data points and an Excel chart. Will you tell me what I need to do? It’s too hard, right?”
This abundance challenge led Sleep AI to strategic positioning that avoided commodity competition. Rather than building better wearables, they built the intelligence layer that processes data from any source—phones, Apple Watches, Whoop, Oura, or no device at all.
“We are agnostic as to whether you want to wear a whoop or a ring or nothing at all,” Colin states. “We’re agnostic because really, we’re not trying to sell a measurement system. What we’re really doing is using the data intelligently to help people achieve better outcomes.”
The technical requirements for this positioning explain the eight-year timeline: gold-standard measurement protocols, machine learning models identifying sleep disruption root causes, and clinical validation through hundreds of published studies. You can’t fake this credibility with marketing.
Infrastructure Positioning for Billion-User Scale
After proving their science through R&D partnerships and publications, Sleep AI launched their highest-leverage product: SDK and API infrastructure that embeds sleep intelligence into any health application.
The strategic insight: “If you want to help a person to lose weight or to get fit or to conceive a baby or to manage diabetes or to deal with some chronic health condition, you cannot be successful without sleep.” Every health app needs sleep optimization, but building that capability internally requires years of specialized research most companies can’t justify.
Colin’s target: “Our goal is we want to reach and touch a billion or more people through those SDKs and APIs, because that’s how we really make a difference.” Each integration becomes a distribution channel—fitness apps, fertility trackers, diabetes management platforms all delivering Sleep AI’s recommendations to their existing users.
This infrastructure play emerged from recognizing complexity constraints. “We decided we don’t think there’s any company on earth that can solve human sleep alone,” Colin explains. “There isn’t, because there’s too many interventions required, too many potential diagnosis on the medical side.” Rather than attempting vertical integration, Sleep AI horizontally enables every company addressing adjacent health problems.
Regulatory Approval as Competitive Moat
Parallel to building their SDK business, Sleep AI achieved a breakthrough in regulated healthcare markets: full reimbursement approval in Germany without prescription requirements.
“74 million people in Germany can download and use that Deinschlaff by Sleep AI app, and their health insurer must pay for it by law, without the need for a doctor’s prescription,” Colin shares. “That’s a huge breakthrough because the German government gets it.”
This approval required multi-year clinical validation that competitors must now replicate to achieve similar status. Beyond creating a revenue stream, the German approval signals product rigor to enterprise buyers evaluating Sleep AI’s SDK. Regulatory wins in healthcare function as third-party validation that marketing claims cannot provide.
Embedding Scientists in Commercial Processes
Transitioning from R&D to commercialization typically requires either culture change or organizational separation. Colin chose neither. Instead, he reframed commercialization as mission-critical to the original scientific purpose.
“Innovation and scientific breakthroughs are great if they have an impact, but if they stay in a box or in a book on a shelf or in a computer file, they have no impact,” he tells his team. “Our duty, once we know how to use an insight to improve people’s sleep, we have to get it out there.”
This framing enables an unusual go-to-market structure: “Our scientists talk to our customers or our prospective customers. They’re part of the sales process from the beginning to the end, because that is the culture.” Rather than handoffs between technical and commercial teams, Sleep AI’s deepest technical experts own customer relationships throughout the sales cycle.
The company maintains clear ethical boundaries during commercialization. “We will never, ever sell somebody’s data because they don’t want us to and we’ve agreed not to,” Colin states. “We are never going to be an ad platform because we don’t believe in promoting something that we don’t have scientific evidence around.”
These constraints eliminate potential revenue streams but reinforce trust—critical for infrastructure positioning where customers integrate your technology into their core products.
Building Commercial Motion After Establishing Category Authority
Sleep AI only launched formal sales and marketing functions in the last nine to twelve months. Their current go-to-market approach combines several channels: structured referral programs between existing SDK customers, ecosystem partnerships with complementary health tech companies, and finally, public storytelling about their technical achievements.
Colin’s long-game thesis: when you’re selling infrastructure that companies will embed in their products, technical credibility trumps sales velocity. The eight years spent collecting a billion hours of data, publishing 100+ studies, and achieving regulatory approval created competitive separation that aggressive early commercialization couldn’t have matched.
“We want Sleep AI to touch a billion people or more through the companies that they already trust by being their trusted sleep partner,” Colin envisions. The distribution model—reaching consumers through partners rather than direct channels—requires the kind of scientific authority that only patient technical investment can build.
For deep-tech B2B founders, Sleep AI’s path demonstrates an alternative to the standard venture playbook: build undeniable technical superiority first, let initial customers find you through reputation, then scale commercial operations from a position of category-defining strength rather than fighting for credibility while simultaneously building product.
Recommended Founder
Interviews
Samson Magid
Co-Founder and CEO of HealthSnap
Samson Magid, Co-Founder and CEO of HealthSnap: Over $12 Million Raised to Build the Future of Remote Patient Monitoring
Ganesh Padmanabhan
CEO & Founder of Autonomize AI
How Autonomize AI built credibility with healthcare buyers | Ganesh Padmanabhan
Jack McInnes
Director of Marketing of Corti AI
Building Developer Trust in Healthcare AI Without Hype
Kyle Kiser
CEO of Arrive Health
Kyle Kiser, CEO of Arrive Health: Over $40 Million Raised to Improve the Value of Healthcare Through Informed Decision-Making
Nick Soman
CEO & Founder of Decent
Nick Soman, CEO & Founder of Decent: $43 Million Raised to Build the Future of Direct Primary Care
Amar Kendale
President and Co-Founder of Homeward
Amar Kendale, President & Co-Founder of Homeward: $70 Million Raised to Transform Rural Healthcare Through Technology
Stacy Edgar
CEO and Co-Founder of Venteur
Stacy Edgar, CEO & Co-Founder of Venteur: $7.6 Million Raised to Build the Future of Health Insurance
Torben Nielsen
CEO & Co-Founder of Uptiv Health
Torben Nielsen, CEO of Uptiv Health: $7.5M Raised to Build the Future of Infusion Therapy Through Technology-Enabled Retail Centers
Austin McChord
CEO of Casana
Austin McChord, CEO of Casana: Over $46 Million Raised to Create the Future of In-Home Health Monitoring
Michael Passanante
Senior Vice President of Marketing and Communications of Capital Rx
How to Build 18-Month Attribution Models That Actually Work
Derek Streat
Co-Founder & Chief Executive Officer of Dexcare
Derek Streat, CEO of Dexcare: $110 Million Raised to Help Health Systems to Find Time for the Best Care
Alfred Griffin
CEO and Co-Founder of CEO and Co-Founder
Alfred Griffin, CEO and Co-Founder of LightForce: $150 Million Raised to Power the Future of Orthodontics
Richard Queen
CEO and Co-Founder of DignifiHealth
Richard Queen, CEO and Co-Founder of DignifiHealth: $7 Million Raised to Drive Better Patient Outcomes in Rural Healthcare and Beyond
Joshua Miller
CEO and Co-Founder of Gradient Health
Joshua Miller, CEO & Co-Founder of Gradient Health: $5.7 Million Raised to Build the Future of Medical Imaging
David Berry
CEO and Founder of Valo
David Berry, CEO and Founder of Valo: Over $500 Million Raised to Build the Future of Drug Discovery
Kourosh Davarpanah
Co-Founder and CEO of Inato
Kourosh Davarpanah, Co-Founder and CEO of Inato: Over $35 Million Raised to Build the Future of Clinical Trials
Khaled Boukadoum
Founder of Torch Dental
Khaled Boukadoum, Founder of Torch Dental: $49.5 Million Raised to Transform Dental Supply Management Through Digital Innovation
Dr Thomas Oakley
CEO of Feedback PLC
Dr Thomas Oakley, CEO of Feedback PLC: £20 Million Raised to Build the Future of Patient Data Sharing
Verena Gerhardus
Director of Growth of Nelly Solutions
How Nelly Grew 3X Through Meta Ads in Health Tech
Vicky Demas
CEO of Identifeye Health
Vicky Demas, CEO of identifeye HEALTH: $90 Million Raised to Power the Future of Retinal Imaging
Hala Borno
Founder and CEO of Trial Library
Hala Borno, Founder and CEO of Trial Library: $5M Raised to Improve Patient Recruitment and Diversity in Oncology Clinical Trials
Corey Washington
Senior Marketing Manager of Amenities Health
Humanizing Healthcare Tech: Marketing Lessons from Amenities
Itzik Cohen
Co-Founder and CEO of PayZen
Itzik Cohen, Co-Founder and CEO of PayZen: $240 Million Raised to Build the Future of Affordable Health Care
Mike Desjadon
CEO of Anomaly
Why Anomaly avoids annual curiosity revenue (ACR) — and you probably should to | Mike Desjadon ($30M Raised)
Brandon Young
CMO of Garner Health
Why Marketing Lost Its Craft (And How AI Could Force It Back)
Michael Chang
Mastering Market Fit in AI: Insights from Michael Chang, Director of Marketing at ArteraAI
Scott Chetham
CEO & Co-Founder of
The ROI system Faro Health uses to convert enterprise pilots | Scott Chetham
Danny Freed
CEO & Founder of Blueprint
Danny Freed, CEO & Founder of Blueprint: $13.7 Million Raised to Build the Future of Therapist Enablement
Teodor Grantcharov
Founder of Surgical Safety Technologies Inc.
How Surgical Safety Technologies targeted the most challenging customers first (massive hospitals) | Teodor Grantcharov
Trey Sutten
CEO & Co-Founder of Siftwell Analytics
Trey Sutten, CEO & Co-Founder of Siftwell Analytics: $5 Million Raised to Transform Healthcare Analytics with AI-Powered Predictions
Dr. Nan-Wei Gong
CEO and Founder of FIGUR8
Dr. Nan-Wei Gong, CEO & Founder of FIGUR8: $40 Million Raised to Build the Future of Musculoskeletal Health and Injury Data Solutions
Daniel Lambert
CEO of PathologyWatch
Daniel Lambert, CEO of PathologyWatch: Over $50 Million Raised to Build the Future of Digital Pathology
Galia Rosen Schwarz
CEO & Co-Founder of C8 Health
How C8 Health broke into more than 100 hospital systems | Galia Rosen Schwarz
Ty Allen
CEO of SocialClimb
Ty Allen, CEO of SocialClimb: $12 Million Raised to Power the Future of Healthcare Marketing
James Bates
CEO and Founder of AdviNOW Medical
James Bates, CEO and Founder of AdviNOW Medical: $24 Million Raised to Build the Future of AI-Powered Healthcare
David King Lassman
Founder of GigXR
David King Lassman, Founder of GigXR: $7 Million Raised to Bring Immersive Learning to Healthcare
Matthew Stoudt
CEO and Founder of AppliedVR
Matthew Stoudt, CEO and Founder of AppliedVR: Over $70 Million Raised to Build the Future of Chronic Pain Relief
Elad Ferber
CEO & Co-Founder of Synthpop
Elad Ferber, CEO & Co-Founder of Synthpop: $8 Million Raised to Build the Future of Healthcare Administration with AI
Ari Ashkenas
SVP Customer Success and Experience of Apploi
How Apploi uses 30/60/90-day check-ins to drive platform adoption and prevent customer drift | Ari Ashkenas
Matt Pavelle
Co-founder and co-CEO of Doctronic
How Doctronic became the first AI licensed to practice medicine through Utah’s regulatory sandbox | Matt Pavelle
Justin Dearborn
Founder & CEO of Praia Health
Justin Dearborn, Founder & CEO of Praia Health: $20 Million Raised to Build the Future of Consumer Experience in Healthcare
Cesar Herrera
CEO and Co-Founder of Yuvo Health
Cesar Herrera, CEO and Co-Founder of Yuvo Health: $28 Million Raised to Revolutionize Healthcare Access
Alexandra Ferraro
Head of Marketing of Intelligencia AI
Beyond Perfect: Healthcare Tech Marketing That Drives Real Revenue
Karsten Miermans
CEO of hema.to GmbH
How hema.to uses clinical evidence as their core marketing strategy in healthcare AI | Karsten Miermans
Kevin Flyangolts
CEO and Founder of Aclid
Kevin Flyangolts, CEO & Founder of Aclid: $4 Million Raised to Build the Future of Biosecurity
Arif Nathoo
CEO and Co-Founder of Komodo Health
Arif Nathoo: the Story of Komodo Health ($3 Billion Valuation)
Rafid Fadul
CEO and Co-Founder of Zivian Health
Rafid Fadul, CEO and Co-Founder of Zivian Health: $3 Million Raised to Power the Future of Compliant Healthcare Collaborations
Matt Renfro
Co-Founder & CEO of Lynx
Matt Renfro, CEO of Lynx: $17.5 Million raised to Bring Modern Fintech to Healthcare
Rebecca McNeil
VP of Marketing of SureCost
Why This VP of Marketing Abandoned Paid Media Completely
Kristen Valdes
CEO & Founder of B.well
Kristen Valdes, CEO & Founder of B.well: $100 Million Raised to Reimagine the Healthcare Experience
Oliver Kharraz
CEO & Founder of Zocdoc
How Zocdoc survived near death, increased prices up to 100x, and turned around the company | Oliver Kharraz
Dilpreet Sahota
CEO of Trek Health
Dilpreet Sahota, CEO of Trek Health: $3 Million Raised to Help Mental Health Providers Accept Insurance
Senan Ebrahim
CEO & Founder of Delfina
Senan Ebrahim, CEO & Founder of Delfina: $10 Million Raised to Build the Future of Intelligent Pregnancy Care
Cody Simmons
CEO of DermaSensor
Cody Simmons, CEO of DermaSensor: $36 Million Raised to Build the First AI-Powered Skin Cancer Detection Tool for Primary Care
Dipanwita Das
CEO and Co-Founder of Sorcero
Dipanwita Das, CEO and Co-Founder of Sorcero: Over $20 Million Raised to Power Medical Affairs Teams of the Future
Dimitrios Skaltsas
CEO & Co-Founder of Intelligencia AI
Dimitrios Skaltsas, CEO & Co-Founder of Intelligencia AI: $15.5 Million Raised to Build the Future of Drug Development
Nabeel Kaukab
Founder and CEO of Phamily
How Phamily built an eight-figure ARR healthcare company without discounting: The subsidized R&D approach | Nabeel Kaukab ($25M Raised)
Michael Gorton
Founder of Teladoc
Teladoc Founder Michael Gorton on the Early Days of Pioneering the Telemedicine Category (And What’s He’s Up to Next)
Alex Zekoff
CEO and Co-Founder of Thoughtful AI
Alex Zekoff, CEO and Co-Founder of Thoughtful AI: $21 Million Raised to Power the Future of Healthcare Automation
Marshall Darr
CEO & Co-Founder of StretchDollar
How StretchDollar drives leads from LLM search | Marshall Darr
Mark Lehmkuhle
CEO & Founder of Epitel
Mark Lehmkuhle, CEO & Founder of Epitel: $20 Million Raised to Build the Future of Brain Health Monitoring
Gregory Stein
CEO of Shadowbox
How Shadowbox evolved it’s ICP from desperate labs to health systems with 500-1,000 community providers | Gregory Stein
Daniel West
CEO of Prospection
Daniel West, CEO of Prospection: $36 Million Raised to Build the Future of Patient-Centric Intelligence
Brian Whorley
Founder & CEO of Paytient
Behind the Scenes: How This Healthcare Founder Prepared to Testify Before Congress | Brian Whorley
Avi Singer
CEO & Founder of Showd.me
Avi Singer, CEO & Founder of Showd.me: $4.5 Million Raised to Build the Future of Compliance Training
Brad Kittredge
CEO & Co-Founder of Brightside
Brad Kittredge, CEO & Co-Founder of Brightside: $150 Million Raised to Build the Future of Mental Healthcare
Jocelyn Nowak
Marketing & Sales Enablement Lead of FIGUR8
Integrity-Driven Marketing: FIGUR8’s Path to 3,000+ Clinics
Todd Zion
Founder of Akston Biosciences
Todd Zion, Founder of Akston Biosciences: From a $500M Exit to Pioneering Biotech Innovation in Pet Health
Viral Patel
Founder and CEO of Radish Health
Viral Patel, CEO of Radish Health: $5 Million Raised to Connect Employees with a Better Healthcare Experience
Thomas Knox
CEO & Founder of VitVio
Thomas Knox, CEO & Founder of VitVio: $10 Million Raised to Transform Surgical Operations Through AI-Powered Automation
Ophir Ronen
CEO of CalmWave
How CalmWave positioned transparent AI over black box algorithms to win hospital C-suite validation | Ophir Ronen
Aasim Saeed
CEO and Founder of Amenities Health
Aasim Saeed, CEO and Founder of Amenities Health: $10 Million Raised to Build the Future of Patient Engagement
Omer Maman
VP of Marketing of Healthee
Why AI Should Enhance, Not Replace Your Marketing Team
Armon Sharei
CEO & Founder of Portal
Armon Sharei, CEO & Founder of Portal: $5 Million Raised to Power the Future of Cell Engineering
Joe Gagnon
CEO of 1upHealth
Joe Gagnon, CEO at 1upHealth: Over $75 Million Raised to Build the Future of Healthcare Data
Henry O’Connell
CEO & Founder of Canary Speech
Henry O’Connell, CEO & Founder of Canary Speech: $26 Million Raised to Build the Future of Vocal Biomarker Technology
Mariano García-Valiño
Founder, Chief Engineer and CEO of Axenya
How Axenya achieved cash flow positive before Series A by proving recontract capability | Mariano García-Valiño
Elizabeth Wiet
Senior Vice President Marketing of VieCure
Why This Healthcare Marketer Is Abandoning Trade Show Booths w Elizabeth Wiet
Ben Albert
CEO & Co-Founder of Upfront Healthcare
Ben Albert, CEO & Co-Founder of Upfront Healthcare: $30 Million Raised to Power the Future of Patient Engagement
Brock Leonti
CEO & Co-Founder of Prescribe FIT
Brock Leonti, CEO & Co-Founder of Prescribe FIT: $15 Million Raised to Build the Future of Orthopedic Care
Brett Kleger
CEO of Datacubed Health
Brett Kleger, CEO of Datacubed Health: $43 Million Raised to Revolutionize Clinical Trial Data Collection
Andreas Cleve
CEO and Co-Founder of Corti
Andreas Cleve, CEO and Co-Founder of Corti: $32 Million Raised to Power the Future of Patient Consultations
Ignacio Medrano
Founder & CMO of Savana
Ignacio Medrano, Founder & CMO of Savana: $44M Raised to Transform Healthcare Intelligence Through AI
Ian Prendergast
CEO and Co-Founder of Toothio
How Toothio built credibility as non-industry founders through strategic SME hires | Ian Prendergast
Veer Gidwaney
CEO & Founder of Ansel Health
Veer Gidwaney, CEO & Founder of Ansel Health: $50 Million Raised to Transform Supplemental Health Insurance
Rishi Nayyar
CEO and Co-Founder of PocketHealth
Rishi Nayyar, CEO and Co-Founder of PocketHealth: $22.5 Million Raised to Power the Future of Medical Image Sharing
Trenor Williams
CEO and Co-Founder of Socially Determined
Trenor Williams, CEO and Co-Founder of Socially Determined: $34 Million Raised to Build the Social Risk Intelligence Category
Amy Brown
CEO and Founder of Authenticx
Amy Brown, CEO and Founder of Authenticx: $28 Million Raised to Build the Future of Listening AI
Joseph Schneier
CEO of Trusty Care
Joseph Schneier, CEO of Trusty Care: $13+ Million Raised to Shape the Future of Medicare